GSK
GSK plc NYSE Listed Mar 28, 1980$50.51
Mkt Cap $101.6B
52w Low $35.45
57.4% of range
52w High $61.70
50d MA $55.16
200d MA $48.22
P/E (TTM)
18.7x
EV/EBITDA
7.6x
P/B
6.5x
Debt/Equity
1.1x
ROE
—
P/FCF
12.7x
RSI (14)
—
ATR (14)
—
Beta
0.35
50d MA
$55.16
200d MA
$48.22
Avg Volume
5.3M
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
980 Great West Road · Brentford TW8 9GS · GB
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 1.16 | 1.24 | +6.9% | 51.40 | +1.0% | +1.8% | +0.4% | -1.0% | -2.0% | -1.7% | — |
| Feb 4, 2026 | TNS | 0.64 | 0.68 | +6.2% | 57.23 | +1.0% | +3.4% | +5.2% | +3.1% | +2.8% | +2.2% | — |
| Oct 29, 2025 | TNS | 1.26 | 1.48 | +17.5% | 45.93 | +0.0% | +2.2% | +2.0% | +0.9% | +1.9% | +1.7% | — |
| Jul 30, 2025 | TNS | — | 0.96 | — | 38.97 | -3.9% | -4.7% | -3.6% | -3.3% | -4.2% | -5.7% | — |
| Apr 30, 2025 | TNS | 1.08 | 1.13 | +4.6% | 39.85 | -1.1% | -2.8% | -2.0% | -2.5% | -5.9% | -6.7% | — |
| Feb 5, 2025 | TNS | 0.44 | 0.59 | +34.1% | 37.70 | -0.5% | -3.5% | -4.4% | -3.3% | -4.3% | -4.2% | — |
| Oct 30, 2024 | TNS | 1.16 | 1.27 | +9.5% | 37.01 | -2.0% | -0.7% | -0.4% | -0.1% | +0.0% | -3.0% | — |
| Jul 31, 2024 | TNS | 1.00 | 1.09 | +9.0% | 38.77 | +0.3% | +2.2% | +4.3% | +1.6% | -0.2% | +1.5% | — |
| Jan 31, 2024 | TNS | 0.76 | 0.72 | -5.3% | 39.44 | +1.3% | +3.0% | +3.2% | +5.4% | +5.9% | +6.5% | — |
| Nov 1, 2023 | TNS | 1.09 | 1.26 | +15.6% | 34.58 | -1.7% | -1.2% | -0.4% | +0.6% | +1.2% | +1.4% | — |
| Jul 26, 2023 | TNS | 0.87 | 0.97 | +11.5% | 35.87 | +1.0% | +0.0% | -1.2% | -0.8% | -2.6% | -3.5% | — |
| Apr 26, 2023 | TNS | 0.82 | 0.90 | +9.8% | 35.93 | +0.3% | +0.2% | +0.3% | +0.8% | +1.2% | +2.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6 | Barclays | Downgrade | Equal Weight → Underweight | — | $49.02 | $50.69 | +3.4% | +3.1% | +3.3% | +2.4% | +2.8% | +2.8% |
| Nov 12 | Jefferies | Downgrade | Buy → Hold | — | $36.35 | $35.50 | -2.3% | -2.3% | -3.4% | -5.4% | -8.3% | -7.3% |
| Oct 31 | Guggenheim | Downgrade | Buy → Neutral | — | $37.01 | $36.27 | -2.0% | -0.7% | -0.4% | -0.1% | +0.0% | -3.0% |
| Jul 8 | UBS | Downgrade | Buy → Neutral | — | $38.84 | $38.85 | +0.0% | -0.3% | -0.6% | -0.7% | +0.2% | +0.8% |
| Jul 2 | Jefferies | Maintains | Buy → Buy | — | $38.38 | $38.11 | -0.7% | -0.4% | +0.2% | +1.2% | +0.9% | +0.6% |
| Mar 4 | Guggenheim | Upgrade | Neutral → Buy | — | $42.03 | $42.04 | +0.0% | +1.0% | +1.4% | +1.4% | +3.7% | +2.6% |
| Jan 3 | Jefferies | Upgrade | Hold → Buy | — | $37.51 | $38.11 | +1.6% | +3.8% | +4.2% | +4.5% | +5.7% | +6.0% |
| Feb 11 | DZ Bank | Downgrade | Buy → Hold | — | $44.44 | $44.37 | -0.2% | -0.3% | -3.5% | -1.8% | -2.4% | -2.5% |
| Nov 5 | Barclays | Upgrade | Underweight → Equal Weight | — | $43.00 | $43.00 | +0.0% | +1.1% | -0.5% | -0.6% | +0.4% | +0.5% |
| Mar 23 | SVB Leerink | Downgrade | Outperform → Market Perform | — | $36.67 | $36.25 | -1.1% | -1.9% | -2.2% | -1.6% | +0.0% | +0.1% |
| Feb 4 | Deutsche Bank | Downgrade | Hold → Sell | — | $35.42 | $35.74 | +0.9% | -0.1% | -0.5% | +0.1% | +0.9% | +0.3% |
| Jan 15 | Deutsche Bank | Maintains | Hold → Hold | — | $38.16 | $38.41 | +0.7% | +0.8% | +1.0% | -0.4% | -1.0% | +0.5% |
| Nov 21 | UBS | Upgrade | Neutral → Buy | — | $43.92 | $43.99 | +0.2% | +0.3% | +0.2% | +1.3% | +2.0% | +3.5% |
| Nov 11 | Argus | Maintains | Buy → Buy | — | $44.42 | $44.03 | -0.9% | -0.4% | +0.2% | +0.5% | -1.3% | -0.7% |
| Oct 16 | New Street | Upgrade | Reduce → Hold | — | $42.27 | $42.45 | +0.4% | +0.0% | +0.5% | +0.6% | +0.8% | +0.6% |
| Oct 11 | Cantor Fitzgerald | Upgrade | Hold → Buy | — | $42.25 | $42.15 | -0.2% | -0.2% | -0.2% | +0.0% | +0.1% | +0.5% |
| Sep 3 | Societe Generale | Upgrade | Sell → Buy | — | $41.58 | $41.81 | +0.6% | +2.0% | +1.9% | +1.3% | +1.2% | -0.2% |
| Jan 14 | Exane BNP Paribas | Downgrade | Outperform → Neutral | — | $39.38 | $38.73 | -1.7% | -2.0% | -0.8% | -2.5% | -1.0% | -0.8% |
| Dec 14 | Morgan Stanley | Maintains | Underweight → Underweight | — | $37.94 | $37.58 | -0.9% | -0.9% | -2.3% | -2.2% | -1.4% | -0.1% |
| Dec 14 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $37.94 | $37.58 | -0.9% | -0.9% | -2.3% | -2.2% | -1.4% | -0.1% |
| Dec 6 | Barclays | Downgrade | Overweight → Equal Weight | — | $38.34 | $37.00 | -3.5% | -2.4% | -2.7% | -1.7% | -2.6% | -1.7% |
| Aug 20 | Argus | Maintains | Buy → Buy | — | $41.25 | $41.21 | -0.1% | +0.2% | +0.6% | +0.7% | -0.2% | +0.1% |
| May 5 | Argus | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 5 | Argus | Upgrade | Hold → Buy | — | — | — | — | — | — | — | — | — |
| Oct 26 | Bank of America | Downgrade | Buy → Neutral | — | $38.19 | $37.29 | -2.4% | -4.2% | -5.1% | -3.9% | -4.6% | -5.2% |
| Jul 5 | Citigroup | Downgrade | Buy → Neutral | — | $42.77 | $42.35 | -1.0% | -0.3% | -1.2% | -1.2% | -1.3% | -1.8% |
| Sep 23 | PiperJaffray | Maintains | Overweight → Overweight | — | $43.58 | $43.20 | -0.9% | -0.4% | -1.4% | -0.6% | +0.2% | -1.6% |
| Sep 14 | Exane BNP Paribas | Downgrade | Neutral → Underperform | — | $42.51 | $43.01 | +1.2% | +1.5% | +2.4% | +0.9% | +1.9% | +1.3% |
| Aug 12 | Argus | Maintains | Buy → Buy | — | $44.39 | $44.45 | +0.1% | -0.5% | +0.0% | -0.2% | +0.0% | +0.2% |
| Jul 14 | Jefferies | Upgrade | Hold → Buy | — | $43.75 | $44.13 | +0.9% | +0.3% | +0.4% | +1.1% | -0.1% | +0.8% |
| Feb 26 | Cantor Fitzgerald | Maintains | Hold → Hold | — | $39.50 | $39.32 | -0.5% | -0.9% | -2.1% | +0.4% | -0.3% | -0.8% |
| Jan 27 | Bryan Garnier | Upgrade | Neutral → Buy | — | $40.83 | $41.05 | +0.5% | -0.6% | -0.5% | +1.1% | +1.3% | +0.2% |
| Oct 20 | Credit Suisse | Upgrade | Underperform → Neutral | — | $41.74 | $41.94 | +0.5% | -1.4% | -2.1% | -0.7% | +0.9% | +0.8% |
| Oct 12 | JP Morgan | Upgrade | Underweight → Neutral | — | $40.22 | $40.00 | -0.5% | +0.4% | -0.3% | +1.0% | +3.3% | +4.3% |
| Jun 4 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $44.03 | $43.60 | -1.0% | -2.0% | -3.3% | -4.1% | -4.2% | -2.5% |
| Jul 28 | Mainfirst | Maintains | Underperform → Underperform | — | $48.60 | $48.67 | +0.1% | -0.8% | -1.2% | -0.3% | -0.5% | -1.2% |
| Apr 23 | Argus | Upgrade | Hold → Buy | — | $55.30 | $55.50 | +0.4% | -0.3% | +0.4% | +0.8% | +1.3% | +2.0% |
| Apr 22 | Panmure | Upgrade | Hold → Buy | — | $53.12 | $55.52 | +4.5% | +4.1% | +3.8% | +4.5% | +5.0% | +5.4% |
| Jan 27 | S&P Capital IQ | Upgrade | Sell → Hold | — | $53.33 | $53.38 | +0.1% | -0.4% | -0.1% | -2.4% | -2.6% | -3.4% |
| Jan 24 | Berenberg | Downgrade | Buy → Hold | — | $54.90 | $54.02 | -1.6% | -2.9% | -3.3% | -3.0% | -5.2% | -5.4% |
| Jan 22 | Cowen & Co. | Downgrade | Outperform → Market Perform | — | $54.95 | $55.00 | +0.1% | -0.4% | -0.1% | -2.9% | -3.3% | -3.1% |
| Jan 9 | UBS | Maintains | Neutral → Neutral | — | $52.73 | $53.27 | +1.0% | +0.2% | +0.0% | -1.6% | -0.3% | +1.2% |
| Dec 17 | Deutsche Bank | Downgrade | Buy → Hold | — | $51.89 | $51.07 | -1.6% | -1.6% | -1.1% | -0.6% | -1.0% | -0.6% |
| Nov 12 | Panmure | Downgrade | Buy → Hold | — | $53.03 | $52.01 | -1.9% | -1.6% | -2.1% | -1.7% | -1.8% | -1.9% |
| Oct 10 | Credit Suisse | Downgrade | Neutral → Underperform | — | $49.31 | $49.01 | -0.6% | +0.8% | +1.0% | +2.1% | +1.6% | +2.0% |
| Oct 8 | MainFirst | Upgrade | Underperform → Outperform | — | $50.13 | $49.94 | -0.4% | -1.2% | -1.6% | -0.9% | -0.7% | +0.4% |
| Sep 16 | Barclays | Downgrade | Overweight → Equal Weight | — | $51.41 | $51.87 | +0.9% | -0.2% | -0.5% | -0.3% | -2.2% | -1.7% |
| Aug 21 | Cowen & Co. | Upgrade | Market Perform → Outperform | — | $51.85 | $52.17 | +0.6% | +0.0% | +0.4% | +0.7% | +0.6% | -0.2% |
| Aug 15 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $51.92 | $51.35 | -1.1% | -0.8% | -0.6% | -1.2% | -0.1% | -0.1% |
| Aug 14 | JP Morgan | Upgrade | Underweight → Neutral | — | $52.01 | $52.35 | +0.7% | -0.2% | -0.9% | -0.7% | -1.3% | -0.3% |
No insider trades available.
No recent filings available.
Data updated apr 26, 2026 10:46am
· Source: massive.com